1. 2MACE score predicts cardiovascular adverse events in real-world atrial fibrillation patients under rivaroxaban therapy. Data from EMIR study. (14th October 2021) Authors: Esteve Pastor, M; Marin, F; Anguita, M; Sanmartin, M; Rafols, C; Arribas Ynsaurriaga, F; Baron Esquivas, G; Barrios, V; Cosin Sales, J; Freixa Pamias, R; Perez Cabeza, A; Vazquez Rodriguez, J M; Lekuona Goya, I Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Incidence of cardiovascular events in patients with atrial fibrillation anticoagulated with rivaroxaban after 2.5 years of follow-up: not all is stroke or bleeding. (14th October 2021) Authors: Anguita Sanchez, M; Ruiz Ortiz, M; Marin, F; Sanmartin, M; Rafols, C; Masjuan, J; Urena, I; Baron Esquivias, G; Lekuona, I; Perez Cabeza, A; Vazquez Rodriguez, J.M Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Oral anticoagulation therapy with rivaroxaban in elderly patients with atrial fibrillation. Results from EMIR study. (14th October 2021) Authors: Esteve Pastor, M; Marin, F; Anguita, M; Sanmartin, M; Rafols, C; Roldan, V; Perez, C; Barrios, V; Lekuona Goya, I; Perez Cabeza, A; Cosin Sales, J Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P3853Switching to non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients taking vitamin K antagonists: a 1-year report of the SULTAN registry. (28th August 2018) Authors: Rivera Caravaca, J M; Marin, F; Esteve-Pastor, M A; Ferreira, I; Badimon, L; Rafols, C; Ruiz-Ortiz, M; Anguita, M Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Predictors of adverse clinical outcomes in atrial fibrillation patients with concomitant renal impairment under rivaroxaban therapy. (14th October 2021) Authors: Marin, F; Rivera-Caravaca, J.M; Anguita Sanchez, M; Sanmartin Fernandez, M; Rafols, C; Roldan, V; Recalde, E; Freixa Pamias, R; Lekuona Goya, I; Vazquez Rodriguez, J.M; Perez Cabeza, A Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗